|
English Agenda: International Pharma Congress: Invitation-Only Spanish Compliance Roundtable - Sponsored by FARMAINDUSTRIA
Tuesday, May 21, 2013
No cost; In Spanish with Spanish/English simultaneous translation (see below for agenda in Spanish)
|
|
ENGLISH AGENDA: INTERNATIONAL PHARMA CONGRESS: INVITATION-ONLY SPANISH COMPLIANCE ROUNDTABLE
|
9:30 a.m.
 |
Welcome and Introductions
Jose F. Zamarriego Izquierdo
Director, Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain (Host and Moderator)
|
 |
9:35 a.m.
 |
Press Releases
Julián Zabala
Head of Communications, FARMAINDUSTRIA, Madrid, Spain
|
|
|
10:05 a.m.
 |
Patient Support Programs
Arancha Burgos
Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain
|
|
|
10:35 a.m.
 |
Fees for Services Provided to Healthcare Professionals
Santiago Páramo
Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain
|
|
|
11:05 a.m.
 |
Promotion of Medicines through Digital Channels
Olga Sanz
Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain
|
|
|
|
11:35 a.m. |
Adjournment and Lunch on Your Own
|
Spanish Agenda: Mesa Redonda Accesible Mediante Invitación: Desafíos del Compliance Officer en España
Tuesday, May 21, 2013
Gratuito; en castellano con traducción simultánea Castellano/Inglés.
|
SPANISH AGENDA: MESA REDONDA ACCESIBLE MEDIANTE INVITACIÓN:
DESAFÍOS DEL COMPLIANCE OFFICER EN ESPAÑA
|
9:30 a.m.
|
Bienvenida y Presentaciones
Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain (Moderador)
|
|
|
9:35 a.m.
|
Notas de Prensa
Julián Zabala
Director de Comunicación, FARMAINDUSTRIA, Madrid, Spain
|
|
|
10:05 a.m.
|
Programas de Apoyo a Pacientes
Arancha Burgos
Unidad de Supervisión Deontológica, FARMAINDUSTRIA, Madrid, Spain
Presentation Material (Acrobat)
|
|
|
10:35 a.m.
|
Servicios Prestados por Profesionales Sanitarios
Santiago Páramo
Unidad de Supervisión Deontológica, FARMAINDUSTRIA, Madrid, Spain
Presentation Material (Acrobat)
|
|
|
11:05 a.m.
|
Promoción de Medicamentos en Soportes Digitales
Olga Sanz
Unidad de Supervisión Deontológica, FARMAINDUSTRIA, Madrid, Spain
Presentation Material (Acrobat)
|
|
|
|
11:35 a.m. |
Fin de la Sesión y Comida Libre
|
Agenda: International Pharma Congress: Day I
Tuesday, May 21, 2013
|
DAY I -- ETHICS: MOVING FROM RULES-BASED ONLY "COMPLIANCE"
PROGRAMS TO ETHICS AND COMPLIANCE CULTURES
(In Spanish and English with simultaneous translation)
|
1:00 p.m.
 |
Welcome and Introductions
Roeland Van Aelst
Vice President EMEA & Canada, Health Care Compliance and Privacy, Johnson & Johnson; Board Member and Co-chair, Strategic Committee, International Society of Healthcare Ethics and Compliance Professionals (ethics), Brussels, Belgium (Co-chair)
|
|
|
Jose F. Zamarriego Izquierdo
Director, Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain
|
|
|
1:10 p.m.
 |
International Pharma Congress Vision and Overview
Ann Beasley Bacon
Vice President Corporate Compliance, International, Biogen Idec International, GmbH (as of March 1); Former Global Compliance Officer, Novartis Pharma AG; Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Zug, Switzerland (Co-chair)
|
 |
Dominique Laymand, Esq.
Vice President Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb; President, International Society of Healthcare Ethics and Compliance Professionals (ethics), Paris, France (Co-chair)
Presentation Material (Acrobat)
|
|
|
Roeland Van Aelst
Vice President EMEA & Canada, Health Care Compliance and Privacy, Johnson & Johnson; Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Brussels, Belgium (Co-chair)
Presentation Material (Acrobat)
|
|
|
1:30 p.m.
 |
Gabor Danielfy Memorial Keynote Address: The Role of Global Compliance in the Pharmaceutical Enterprise
Elvira Sanz Urgoiti
Presidente, Pfizer Spain, Presidente, Farmaindustria, Madrid, Spain
|
|
|
2:00 p.m.
 |
Keynote Address and Roundtable: Ethics, Culture and Compliance
Paul Woods, BPharm, MA, MRPharmS
Independent Consultant; Former Global Compliance Director, AstraZeneca, Macclesfield, Cheshire, UK (Moderator)
|
|
|
2:15 p.m.
 |
Keynote Address: Business Ethics for Pharma and Device Companies
Marc Le Menestrel, PhD
Visiting Professor of Ethics, INSEAD; Associate Professor, University Pompeu Fabra (Barcelona), Barcelona, Spain
Presentation Material (Acrobat)
|
|
|
2:45 p.m.
|
Ethics, Culture and Compliance Panel Discussion
Marc Le Menestrel, PhD
Visiting Professor of Ethics, INSEAD; Associate Professor, University Pompeu Fabra (Barcelona), Barcelona, Spain
|
 |
Guido Palazzo, PhD
Professor of Business Ethics, University of Lausanne; Visiting Fellow, Universities of Nottingham and Oxford; Associate Editor, Business Ethics Quarterly, Lausanne, Switzerland
|
 |
Michael Petty, Esq.
Partner, FDA & Life Sciences Group, King & Spalding, Former Vice President of Development and Regulatory Law, Amgen Inc., Former Associate Chief Counsel for Enforcement and Counselor, Division of Import Operations and Policy, US Food and Drug Administration, Washington, DC, USA
|
|
|
Paul Woods, BPharm, MA, MRPharmS
Independent Consultant; Former Global Compliance Director, AstraZeneca, Macclesfield, Cheshire, UK (Moderator)
|
|
|
|
3:30 p.m. |
Break
|
|
|
4:00 p.m.
 |
Roundtable on Integrating Ethics Theory into Ethics Practice
Isaure Kergall-Gayet, Esq.
Vice President, Chief Ethics and Compliance Officer, Ipsen; Former Director, Ethics & Compliance Officer, Member of the Executive Committee, Lilly France, Paris, France
|
 |
Dan Ostergaard
Founder and Chief Executive Officer, Integrity by Design, Former Head of Corporate Integrity and Compliance, Novartis AG, Basel, Switzerland
Presentation Material (Acrobat)
|
 |
Lori Queisser
Principal, Advisory Services, KPMG LLP; Former Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation; Former Member, PCF Executive Committee, Indianapolis, IN, USA
|
|
|
Dominique Laymand, Esq.
Vice President Compliance and Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb; President, International Society of Healthcare Ethics and Compliance Professionals (ethics), Paris, France (Moderator)
|
|
|
4:45 p.m.
 |
Case Study in Stakeholder Relations: The Spanish Market
Healthcare Authorities:
Dr. Antonio Cachá Acosta
Deputy Director General for Evaluation and Control, Healthcare Ministry of the Regional Government, Community of Madrid, Madrid, Spain
|
 |
Neus Rams, PharmD
Deputy Director of Pharmacy and Medical Devices, Ministry of Health, Government of Catalonia, Barcelona, Spain
Presentation Material (Acrobat)
|
 |
Healthcare Professionals:
Dr. Miguel Ángel Caracuel Ruiz
Vice-President, Spanish Federation of Scientific Medical Associations, CientÃfico Médicas Españolas (FACME), Madrid, Spain
Presentation Material (Acrobat)
|
 |
Patient Organisations:
Alfonso Aguaron
International Relations, GEPAC, Madrid, Spain
|
|
|
Moderator:
Jose F. Zamarriego Izquierdo
Director, Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain
|
|
|
|
6:15 p.m. |
Adjournment and Networking Reception
|
|
|
